Prognostic Value of Serial Lactate Dehydrogenase Measurements for Determining Early Mortality in ICU Patients: A Retrospective Cohort Study
Journal of Clinical Medicine · 06.06.2026 · 15 (12) · 4404
DOI: 10.3390/jcm15124404 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.06.2026. Verfasst von Hasan Göze und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul 34480, Türkiye. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Background
This study investigated whether lactate dehydrogenase (LDH) levels measured at ICU admission predict early in-hospital mortality among critically ill medical patients in a single-center retrospective cohort study conducted in Turkey. Specifically, we aimed to (i) determine an optimal LDH threshold; (ii) examine the temporal trajectory of discriminatory performance over 72 h; and (iii) assess LDH as an independent predictor beyond established severity scores.
Methods
In this single-center retrospective cohort study, 681 adults admitted to a medical ICU between January 2015 and January 2025 were analyzed. Serial LDH measurements were obtained at 0, 24, 48, and 72 h after ICU admission. This study was approved by the Institutional Ethics Committee (Decision No.: 2025/99). ROC analysis was performed under a predefined sensitivity constraint (≥0.70), and time-to-event outcomes were examined using Kaplan–Meier methods and Cox proportional hazards regression. Determinants of maximum LDH were assessed using a GLM with Gamma distribution and log link.
Results
The 28-day mortality rate was 39.1%. ROC analysis identified an optimal 24-h LDH cut-off of approximately 275 U/L (AUC = 0.650; sensitivity = 0.70). Discriminatory performance improved progressively over time (AUC of 0.632 at baseline to 0.690 at 72 h), suggesting that serial measurements may capture evolving prognostic information more effectively than single-time-point measurements. Kaplan–Meier analyses demonstrated a stepwise decline in survival with increasing LDH across all categorization approaches (all log-rank p < 0.001). In multivariable Cox models, log-transformed maximum LDH within the first 72 h was the strongest independent predictor of mortality (HR = 2.2–2.6; p < 0.001), demonstrating larger effect sizes than APACHE II, SOFA, and age in fully adjusted models. GLM analysis indicated that male sex was associated with approximately 33% lower expected maximum LDH.
Conclusions
Admission LDH is an independently predictive and readily obtainable prognostic biomarker for early in-hospital mortality in critically ill medical patients. LDH may complement established ICU risk assessment tools, and its integration into clinical workflows as a triage adjunct warrants further evaluation in prospective multicenter studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul 34480, Türkiye.
- Division of Intensive Care, Department of Internal Medicine, Düzce University Faculty of Medicine, Düzce 34295, Türkiye.
ORCID-Profile: Hasan Göze, Türkay Akbaş
Zitieren
APA
Göze, H., & Akbaş, T. (2026). Prognostic Value of Serial Lactate Dehydrogenase Measurements for Determining Early Mortality in ICU Patients: A Retrospective Cohort Study. Journal of Clinical Medicine, 15(12), 4404. https://doi.org/10.3390/jcm15124404
Vancouver
Göze H, Akbaş T. Prognostic Value of Serial Lactate Dehydrogenase Measurements for Determining Early Mortality in ICU Patients: A Retrospective Cohort Study. Journal of Clinical Medicine. 2026;15(12):4404. doi:10.3390/jcm15124404
BibTeX
@article{Gze2026,
author = {Göze, Hasan and Akbaş, Türkay},
title = {Prognostic Value of Serial Lactate Dehydrogenase Measurements for Determining Early Mortality in ICU Patients: A Retrospective Cohort Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4404},
doi = {10.3390/jcm15124404}
}
EUVIMED